ARCHIVES

FDA Official Says Acceptance of PFS “Brings Us In Line With Our European Colleagues.”

This article is from The Cancer Letter archive.

Vol. 32 No. 28 | July 21, 2006

Download PDF Visit The Full Archive

Related Articles

Phase II Study: Proton Therapy Can Have Similar Success Rate, Smaller Level of Risk in Treatment of Hodgkin Lymphoma

July 25, 2014

Letrozole cuts risk of recurrent breast cancer in post-menopausal women.

October 17, 2003

Federal Funding: IOM Report Praises DOD Breast Cancer Research Program

August 15, 1997

TJU Wins NCI Renewal Of Kimmel Center Core Grant; 11 NY Centers Testing Spiral CT.

July 13, 2001

Brooks Wins ACS Award. NCI Would Get $4.725 Billion, 12% Increase, In Bush Budget.

February 8, 2002

The President’s Cancer Panel publishes its annual report

May 6, 2011